| Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity (NCT05036252) | Memorial Sloan Kettering Cancer Center | 2021-08-27 |
| Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study (NCT05223218) | Namida Lab | 2021-08-25 |
| Remote Electronic Assessment of Survivors With Feedback Communication and Directed Referrals (NCT05047575) | University of Wisconsin, Madison | 2021-08-24 |
| Use of an Interactive 3D Tool During Consultation for Breast Reconstruction Surgery (NCT05025020) | Memorial Sloan Kettering Cancer Center | 2021-08-23 |
| Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS) (NCT04383275) | Fudan University | 2021-08-23 |
| Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast Cancer (NCT04987931) | Pfizer | 2021-08-20 |
| Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer (NCT04921137) | Ottawa Hospital Research Institute | 2021-08-19 |
| Postoperative Identification of Tumor Cells At the Lumpectomy Site of Patients with Early Breast Cancer (NCT04339517) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2021-08-17 |
| Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors (NCT05364450) | Indiana University | 2021-08-17 |
| A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer (NCT04946864) | Ascentage Pharma Group Inc. | 2021-08-13 |
| Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) (NCT04568616) | Dartmouth-Hitchcock Medical Center | 2021-08-13 |
| Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma (NCT04849871) | Washington University School of Medicine | 2021-08-12 |
| A Study of PRT1419 in Patients With Advanced Solid Tumors (NCT04837677) | Prelude Therapeutics | 2021-08-11 |
| A Single Arm Pilot Study to Refine a Novel Approach to Exercise Promotion Based on Affect-regulation (NCT04903249) | Dartmouth-Hitchcock Medical Center | 2021-08-10 |
| Study of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer (NCT04881929) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2021-08-09 |
| Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment (NCT04803084) | Laura Kennedy | 2021-08-09 |
| Biology Guided Therapy for Breast Cancer for ER Positive (NCT04965688) | Inova Health Care Services | 2021-08-08 |
| Supporting Women With Breast Cancer to Prepare for Treatment (The Prepare Study) (NCT07221071) | Endeavor Health | 2021-08-05 |
| SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer. (NCT04836520) | Tianjin Medical University Cancer Institute and Hospital | 2021-08-02 |
| Design and Evaluation of the Effects of a Physical Therapy Program With Digital Support in Patients With Breast Cancer (NCT04837248) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2021-08-02 |
| Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound Guidance (NCT04107636) | Radboud University Medical Center | 2021-08-02 |
| Insulin Sensitivity After Breast Cancer (NCT05010356) | University of Copenhagen | 2021-08-01 |
| Copenhagen Master Observational Trial (NCT05145244) | Rigshospitalet, Denmark | 2021-08-01 |
| Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy (NCT04973319) | Shengjing Hospital | 2021-08-01 |
| Effect of Telemonitoring on Functionality, Quality of Life and Risk of Lymphedema in Breast Cancer Survivors (NCT04779450) | University of the State of Santa Catarina | 2021-08-01 |
| Breast Mesh Used in Two-staged Breast Reconstruction (NCT04967976) | Tianjin Medical University Cancer Institute and Hospital | 2021-08-01 |
| TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance) (NCT04936243) | Dana-Farber Cancer Institute | 2021-08-01 |
| Breast Cancer and Kinesiophobia and Physical Activity (NCT05090098) | Acibadem University | 2021-08-01 |
| Precision Breast Conserving Surgery With Guidance. (NCT05708664) | The First Affiliated Hospital with Nanjing Medical University | 2021-08-01 |
| The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study (NCT06220630) | First Affiliated Hospital, Sun Yat-Sen University | 2021-08-01 |
| Magnetic Tracer in the Sentinel Node Procedure in Breast Cancer: the Non-radioactive Alternative for Radio-isotopes (NCT05122585) | Zuyderland Medisch Centrum | 2021-08-01 |
| Observational Analysis of Palbociclib Treatment in Patients With First Line Therapy for Locally Advanced and/or Metastatic Breast Cancer (NCT04874025) | Hospital San Carlos, Madrid | 2021-07-31 |
| Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer (NCT04679454) | European Institute of Oncology | 2021-07-31 |
| Development of a Personalized Discussion Prioritization Tool for Older Adults Considering Adjuvant Chemotherapy for Breast Cancer (NCT05073432) | University of Rochester | 2021-07-28 |
| Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients (NCT05273944) | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 2021-07-28 |
| A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia (NCT04943497) | Novartis Pharmaceuticals | 2021-07-27 |
| Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients (NCT04608357) | Sunnybrook Health Sciences Centre | 2021-07-21 |
| Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy (NCT04137640) | Shengjing Hospital | 2021-07-19 |
| Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer (NCT04136782) | Shengjing Hospital | 2021-07-19 |
| Predicting Chronic Pain Following Breast Surgery (NCT04967352) | University of California, San Diego | 2021-07-19 |
| Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT (NCT04137653) | Shengjing Hospital | 2021-07-19 |
| A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours (NCT04969835) | Avacta Life Sciences Ltd | 2021-07-16 |
| Lighting Intervention for Cancer-related Fatigue (NCT04827446) | University of Michigan Rogel Cancer Center | 2021-07-15 |
| Oncoliq: Early Breast Cancer Detection Based on Liquid Biopsies and microRNAs (NCT06439940) | Oncoliq US Inc | 2021-07-14 |
| The Effect of RadiaAce Gel in the Prevention and Treatment of Radiation Dermatitis in Breast Cancer Patients (NCT04481802) | AceTech | 2021-07-14 |
| Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy (NCT04724499) | Dana-Farber Cancer Institute | 2021-07-14 |
| Phase II Neoadjuvant Pyrotinib Combined with Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial (NCT05165225) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-07-13 |
| Study of the Sexual Health of Patients Treated for Breast Cancer and Followed up in the Observatory of Fertility at Jeanne de Flandre Hospital. (NCT04852926) | University Hospital, Lille | 2021-07-13 |
| Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy (NCT04477616) | The First Affiliated Hospital with Nanjing Medical University | 2021-07-13 |
| Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON) (NCT05036005) | Institut fuer Frauengesundheit | 2021-07-11 |
| Contrast-Free Magnetic Resonance Imaging for Breast Disease (NCT05006196) | Perspectum | 2021-07-06 |
| Shared Decision Making in Surveillance for Distant Metastasis in Breast Cancer (NCT04862078) | Seoul National University Hospital | 2021-07-06 |
| Investigation of a Digital Healthy Habits Program for Individuals With Breast Cancer (NCT04967209) | Noom Inc. | 2021-07-05 |
| Transitioning Care: Perspectives of Older Women With Early Breast Cancer on Current Telemedicine Modalities (NCT04990934) | UNC Lineberger Comprehensive Cancer Center | 2021-07-02 |
| Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer (NCT05292742) | Fujian Medical University Union Hospital | 2021-07-02 |
| Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer (NCT04906395) | Tolmar Inc. | 2021-07-01 |
| Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy (NCT04495387) | University of Florence | 2021-07-01 |
| Pembrolizumab and Paclitaxel in Hormone Receptor-positive, hyperMUTATted Metastatic Breast Cancer Identified by Whole exOme sequeNcing ('MUTATION2') (NCT04946227) | Yonsei University | 2021-07-01 |
| Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D) (NCT04922008) | Fudan University | 2021-07-01 |
| Aromatherapy Methods in Reducing Anxiety Before Breast Biopsy (NCT05276505) | Acibadem University | 2021-07-01 |
| To Evaluate the Cardiac Safety of Pegylated Liposomal Doxorubicin Concurrently Plus Trastuzumab and Pertuzumab in the Adjuvant Setting for Early-stage HER-2-positive Breast Cancer: a Multicenter, Randomized Controlled Clinical Study (NCT05656079) | Shanghai Pudong Hospital | 2021-07-01 |
| RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer (NCT04972448) | Zhejiang Cancer Hospital | 2021-07-01 |
| Improving Survivorship Among Minority Cancer Dyads (NCT04685551) | Charles Drew University of Medicine and Science | 2021-07-01 |
| A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors (NCT04875806) | NextCure, Inc. | 2021-06-30 |
| Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance (NCT04864405) | Ottawa Hospital Research Institute | 2021-06-30 |
| Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer (NCT04354675) | Case Comprehensive Cancer Center | 2021-06-29 |
| Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients (NCT05064098) | University of Colorado, Denver | 2021-06-29 |
| Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer (NCT04941885) | Sun Yat-sen University | 2021-06-25 |
| The ClearCoast™ Magnetic Resonance Outcome PMS Study (NCT05458739) | Clear Cut Medical Ltd. | 2021-06-24 |
| Pre-operative Exercise During Neoadjuvant Chemotherapy in Patients With Breast Cancer (NCT04623554) | Zealand University Hospital | 2021-06-23 |
| Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer (NCT04913532) | Capital Medical University | 2021-06-22 |
| Patient Recall of Cancer Screening and Diagnosis (NCT05014295) | Case Comprehensive Cancer Center | 2021-06-22 |
| IIT2020-20-SHIRAZIP-WALK: Nature Walks (NCT04896580) | Cedars-Sinai Medical Center | 2021-06-21 |
| Online Psychosocial Cancer Screening, Monitoring and Stepped Treatment in Cancer Survivors (NCT04372459) | Institut Català d'Oncologia | 2021-06-21 |
| Validation of Scales in Reconstructive Breast Surgery (NCT05233891) | Vastra Gotaland Region | 2021-06-21 |
| ATEMPT 2.0: Adjuvant T-DM1 vs TH (NCT04893109) | Dana-Farber Cancer Institute | 2021-06-16 |
| Fulvestrant Plus Anlotinib in HR(+)/HER2(-) Metastatic Breast Cancer With FGFR Mutation (NCT04936295) | Sun Yat-sen University | 2021-06-16 |
| Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal Women (NCT04940026) | Sanofi | 2021-06-15 |
| Breast Elasticity Imaging During Neoadjuvant Chemotherapy (NCT04824027) | Columbia University | 2021-06-14 |
| A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer (NCT04927481) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-06-11 |
| TOPS for African American Breast Cancer Survivors (NCT04741802) | Duke University | 2021-06-11 |
| ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer (NCT04889924) | Hospital Universitari de Bellvitge | 2021-06-11 |
| The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer (NCT04874935) | Tanta University | 2021-06-10 |
| Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies (NCT04913337) | NGM Biopharmaceuticals, Inc | 2021-06-09 |
| A Phase II Window of Opportunity Trial of PRMT5 Inhibitor, GSK3326595, in Early Stage Breast Cancer (NCT04676516) | Ottawa Hospital Research Institute | 2021-06-08 |
| The Added Value of a Third Supervised Training Session to a Standard 12-week Rehabilitation Program After Breast Cancer: Pilot Study (NCT05455385) | Universitaire Ziekenhuizen KU Leuven | 2021-06-05 |
| SMS Messaging as a Tool to Improve Cancer Screening Programs (NCT04343950) | Institut Català d'Oncologia | 2021-06-05 |
| Music Intervention for Preoperative Anxiety and Acute Pain Among Mastectomy Patients (NCT04824183) | Chinese University of Hong Kong | 2021-06-05 |
| Histolog Comparison to Standard Histology (NCT04857229) | Imperial College London | 2021-06-04 |
| Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer (NCT04717531) | The First Affiliated Hospital with Nanjing Medical University | 2021-06-03 |
| Refining Local-Regional Therapy for IBC (NCT04636710) | Dana-Farber Cancer Institute | 2021-06-02 |
| Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer (NCT04841148) | Abramson Cancer Center at Penn Medicine | 2021-06-01 |
| Improvement of the Operative Outcome in Patients With Primary VEGF + Unifocal Breast Cancer or DCIS Through the Intraoperative Visualization of the Tumor Using Molecular Imaging and Bevacizumab-IRDye-800CW (NCT05359874) | Technical University of Munich | 2021-06-01 |
| Breast Fractionation Study - Standard Versus Investigational Fractionation Trial - Nodal Radiation (NCT04909125) | Royal North Shore Hospital | 2021-06-01 |
| Registry for Accelerated Partial Breast Irradiation With (SBRT) or (IMRT) (NCT04917640) | GenesisCare USA | 2021-06-01 |
| The Impact of Oral Cryotherapy and Chewing Gum Interventions (NCT07145320) | Hacettepe University | 2021-06-01 |
| Nurse Navigation Program Based On Health Belief Model In Breast Cancer Screening (NaHeB-CaS) (NCT04966377) | Ondokuz Mayıs University | 2021-06-01 |
| Effect of Perioperative CBT on Chronic Persistent Postsurgical Pain Among Breast Cancer Patients (NCT04924010) | Mater Misericordiae University Hospital | 2021-05-31 |
| Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status (NCT04807595) | AstraZeneca | 2021-05-28 |
| A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer (NCT05584644) | Pfizer | 2021-05-24 |